Who
Karen Flynn
Director
Company insider
Files Form 4 as: Director, Stevanato Group S.p.A; Director, Sotera Health; Director, Quanterix; Chief Commercial Officer, Catalent; Director, Recro Pharma; Sr VP & Chief Commercial Offic, West Pharmaceutical Services.
In numbers
- Trades disclosed
- 137
- Buys
- 1
- Sells
- 10
- Bought
- $5,368
- Sold
- $5.9M
- Companies
- 6
- Companies where not an officer
- 4
- First trade
- 24 Jul 2012
- Last trade
- 15 Jun 2026
- Last filed
- 26 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Jun 2026filed 26 Jun 2026 | STVN Stevanato Group S.p.AMedical Devices | SEC FORM 4 Sold | $26K1,493 at $17.09 | filing |
| 15 Jun 2026filed 26 Jun 2026 | STVN Stevanato Group S.p.AMedical Devices | SEC FORM 4 Sold | $26K1,493 at $17.09 | filing |
| 12 Jun 2026filed 26 Jun 2026 | STVN Stevanato Group S.p.AMedical Devices | SEC FORM 4 Code A | —4,975 at $0.00 | filing |
| 12 Jun 2026filed 26 Jun 2026 | STVN Stevanato Group S.p.AMedical Devices | SEC FORM 4 Code A | —4,975 at $0.00 | filing |
| 22 May 2026filed 27 May 2026 | SHC Sotera HealthProviders & Facilities | SEC FORM 4 Code A | —14,970 at $0.00 | filing |
| 22 May 2026filed 27 May 2026 | SHC Sotera HealthProviders & Facilities | SEC FORM 4 Code A | —14,970 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | QTRX QuanterixLife-science tools | SEC FORM 4 Code A | —23,372 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | QTRX QuanterixLife-science tools | SEC FORM 4 Code A | —23,372 at $0.00 | filing |
| 22 May 2025filed 27 May 2025 | SHC Sotera HealthProviders & Facilities | SEC FORM 4 Code A | —19,132 at $0.00 | filing |
| 2 Jan 2025filed 6 Jan 2025 | QTRX Quanterixoption or derivative · Life-science tools | SEC FORM 4 Code A | —15,821 at $0.00 | filing |
| 2 Jan 2025filed 6 Jan 2025 | QTRX QuanterixLife-science tools | SEC FORM 4 Code A | —7,435 at $0.00 | filing |
| 24 May 2024filed 29 May 2024 | SHC Sotera HealthProviders & Facilities | SEC FORM 4 Code A | —20,089 at $0.00 | filing |
| 2 Jan 2024filed 4 Jan 2024 | QTRX Quanterixoption or derivative · Life-science tools | SEC FORM 4 Code A | —6,412 at $0.00 | filing |
| 2 Jan 2024filed 4 Jan 2024 | QTRX QuanterixLife-science tools | SEC FORM 4 Code A | —2,947 at $0.00 | filing |
| 27 Oct 2023filed 31 Oct 2023 | Catalent | SEC FORM 4 Code A | —6,993 at $0.00 | filing |
| 3 Jan 2023filed 4 Jan 2023 | QTRX Quanterixoption or derivative · Life-science tools | SEC FORM 4 Code A | —12,124 at $0.00 | filing |
| 3 Jan 2023filed 4 Jan 2023 | QTRX QuanterixLife-science tools | SEC FORM 4 Code A | —8,083 at $0.00 | filing |
| 3 Jan 2023filed 4 Jan 2023 | QTRX QuanterixLife-science tools | SEC FORM 4 Code A | $12K918 at $12.86 | filing |
| 27 Oct 2022filed 31 Oct 2022 | Catalent | SEC FORM 4 Code A | —4,149 at $0.00 | filing |
| 3 Oct 2022filed 5 Oct 2022 | QTRX QuanterixLife-science tools | SEC FORM 4 Code A | $11K1,066 at $10.48 | filing |
News
No headline names them, or the companies they trade most, lately.